Calcyphosine 抗体 (AA 1-109)
-
- 抗原 See all Calcyphosine (CAPS) 抗体
- Calcyphosine (CAPS)
-
抗原表位
- AA 1-109
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This Calcyphosine antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, RNA Interference (RNAi)
- 原理
- Mouse monoclonal antibody raised against a partial recombinant CAPS.
- 序列
- MDAVDATMEK LRAQCLSRGA SGIQGLARFF RQLDRDGSRS LDADEFRQGL AKLGLVLDQA EAEGVCRKWD RNGSGTLDLE EFLRALRPPM SQAREAVIAA AFAKLDRSG
- 交叉反应
- 人
- 产品特性
- Antibody Reactive Against Recombinant Protein.
- 免疫原
- CAPS (NP_004049, 1 a.a. ~ 109 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- 克隆位点
- 4C6
- 亚型
- IgG1
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 缓冲液
- In 1x PBS, pH 7.4
- 注意事项
- Aliquot to avoid repeated freezing and thawing.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis." in: Journal of neuropathology and experimental neurology, Vol. 66, Issue 6, pp. 505-16, (2007) (PubMed).
: "
-
Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis." in: Journal of neuropathology and experimental neurology, Vol. 66, Issue 6, pp. 505-16, (2007) (PubMed).
-
-